Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

Hepatology

Volumn 37, Issue 3, 2003, Pages 520-527

  Velázquez, Rosario F ^a   Rodríguez, Manuel ^a   Navascués, Carmen A ^b   Linares, Antonio ^a   Pérez, Ramón ^a   Sotorríos, Nieves G ^a   Martínez, Isabel ^a   Rodrigo, Luis ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL DE CABUEÑES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; PROTHROMBIN;

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEROLOGY; STATISTICAL MODEL; THROMBOCYTE COUNT; VALIDATION PROCESS;

EID: 0037369657     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50093     Document Type: Article

References (48)

1. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
2. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
3. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcinoma: a prospective observation of 795 patients with viral and alcoholic cirrhosis. HEPATOLOGY 1993;18:47-53.
4. Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977-985.
5. Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, Virdone R, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alpha fetoprotein. J Hepatol 1994;21:1029-1034.
6. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. HEPATOLOGY 1990;12:680-687.
7. Curley SA, Izzo F, Gallipoli A, De Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 1995;222:375-383.
8. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. HEPATOLOGY 1995;22:432-438.
9. Sheu JC, Sung JL, Chen DS, Lai MY, Wang TH, Yu JY, Yang PM, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study, Cancer 1985;56:660-666.
10. Tanaka S, Kitamura T, Nakanishi K, Okuda S, Yamazaki H, Hiyama T, Fujimoto I. Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma. Cancer 1990;66:2210-2214.
11. Solmi L, Primerano AM, Gandolfi L. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study in 360 cases. Am J Gastroenterol 1996;91:1189-1193.
12. Lok AS, Lai CL. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. HEPATOLOGY 1989;9:110-115.
13. Johnson PJ, Williams R. Cirrhosis and the etiology of hepatocellular carcinoma. J Hepatol 1987;4:140-147.
14. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985;i:1357-1360.
15. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer 1994;74:2234-2238.
16. Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del Ninno E, et al. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. HEPATOLOGY 1999;29:1704-1707.
17. Beasley RP. Hepatitis B virus: the major etiology for hepatocellular carcinoma. Cancer 1988;61:1942-1956.
18. Hasan F, Jeffers LJ, De Medina M, Reddy KR, Parker T, Schiff ER, Houghton M, et al. Hepatitis C-associated hepatocellular carcinoma. HEPATOLOGY 1990;12:589-591.
19. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-1008.
20. Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, Berthelot P. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991;12:70-74.
21. Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Dény P, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. HEPATOLOGY 1996;23:1112-1118.
22. Rodríguez M, Velázquez RF, Linares A, Pérez R, Sotorrío NG, Martínez I, Lauret E, et al. Risk of false positive results (FPR) during a surveillance program for hepatocellular carcinoma (HCC) [Abstract]. HEPATOLOGY 1999;30:281A.
23. Kaplan GL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972;34:187-220.
25. Calvet X, Bruix J, Ginés P, Bru C, Solé M, Vilana R, Rodés J. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. HEPATOLOGY 1990;12:753-760.
26. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001;35:421-430.
27. Prorok PC. Epidemiologic approach for cancer screening. Problems in design and analysis of trials. Am J Pediatr Hematol Oncol 1992;14:117-128.
28. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
29. Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, Naveau S, et al. Independent risk factors for hepatocellular carcinoma in French drinkers. HEPATOLOGY 1991;13:896-901.
30. Garcia-Samaniego J, Rodriguez M, Berenguer J, Rodriguez-Rosado R, Carbo J, Asensi V, Soriano V. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001;96:179-183.
31. El-Serag H, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
32. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. HEPATOLOGY 1993;18:47-53.
33. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. HEPATOLOGY 1997;26(Suppl 1):34S-38S.
34. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2:1004-1006.
35. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis 1999;19:263-269.
36. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;48:251-259.
37. Nagasue N, Ogawa Y, Yukaka H, Ohta N, Ito A. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma. Gastroenterology 1985;88:768-772.
38. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001;34:603-605.
39. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. HEPATOLOGY 1994;19:61-66.
40. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-1133.
41. Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. HEPATOLOGY 1995;21:77-82.
42. Liaw YF, Lin DY, Chen TJ, Chu CM. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver 1989;9:235-241.
43. Kitamura S, Iishi H, Tatsuta M, Ishikawa H, Hiyama T, Tsukuma H, Kasugai H, et al. Liver with hypoechoic nodular pattern as a risk factor for hepatocellular carcinoma. Gastroenterology 1995;108:1778-1784.
44. Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973;26:217-223.
45. Borzio M, Bruno S, Roncalli M, Mels GC, Ramella M, Borzio F, Leandro G, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995;108:812-817.
46. Lee RG, Tsamandas AC, Demetris AJ. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. HEPATOLOGY 1997;26:1415-1422.
47. Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, et al. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients. Am J Gastroenterol 2001;96:1575-1580.
48. Donato MF, Arosio E, Del Ninno E, Ronchi G, Lampertico P, Morabito A, Balestrieri MR, et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. HEPATOLOGY 2001;34:523-528.